Cargando…

Comparison Among Two Liquid Formulations of L-thyroxine in the Treatment of Congenital Hypothyroidism in the First Month of Life: A Pilot Study

The liquid formulation of L-thyroxine is the most used in the substitutive treatment of congenital hypothyroidism (CH). This formulation has higher TSH suppression rates with respect of L-thyroxine tablets and thus lower doses are indicated. Two types of liquid L-thyroxine (Tirosint(©) and Tifactor(...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuli, Gerdi, Munarin, Jessica, de Sanctis, Luisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037062/ https://www.ncbi.nlm.nih.gov/pubmed/35480479 http://dx.doi.org/10.3389/fendo.2022.860775

Ejemplares similares

Diagnostic Re-Evaluation and Potential Predictor Factors of Transient and Permanent Congenital Hypothyroidism in Eutopic Thyroid Gland
por: Tuli, Gerdi, et al.
Publicado: (2021)

Evaluation of the efficacy of EU-TIRADS and ACR-TIRADS in risk stratification of pediatric patients with thyroid nodules
por: Tuli, Gerdi, et al.
Publicado: (2022)

An Overview on Different L-Thyroxine (l-T(4)) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life
por: Stagi, Stefano, et al.
Publicado: (2022)

Pediatric Myxedema Due to Autoimmune Hypothyroidism: A Rare Complication of a Common Disorder
por: Bonino, Elisa, et al.
Publicado: (2023)

Thyroxine Treatment With Softgel Capsule Formulation: Usefulness in Hypothyroid Patients Without Malabsorption
por: Trimboli, Pierpaolo, et al.
Publicado: (2018)

Pediatric thyroid surgery: Retrospective analysis on the first 25 pediatric thyroidectomies performed in a reference center for adult thyroid diseases
por: Quaglino, Francesco, et al.
Publicado: (2023)

l-Thyroxine in an Oral Liquid or Softgel Formulation Ensures More Normal Serum Levels of Free T4 in Patients with Central Hypothyroidism
por: Benvenga, Salvatore, et al.
Publicado: (2017)

“Lymphocyte population in peripheral blood in children and adolescents with graves disease. Potential predictive tool for severity of the disease”
por: Tuli, Gerdi, et al.
Publicado: (2022)

Papillary thyroid microcarcinoma in a boy with Graves’ disease: a case report and review of the literature
por: Tuli, Gerdi, et al.
Publicado: (2021)

“Primary Hyperparathyroidism (PHPT) in Children: Two Case Reports and Review of the Literature”
por: Tuli, Gerdi, et al.
Publicado: (2021)

Distribution of plasma copeptin levels and influence of obesity in children and adolescents
por: Tuli, Gerdi, et al.
Publicado: (2020)

MON-102 Serum Concentrations of FT4 and TSH in the First Six Months of L-Thyroxine Treatment in Infants with Congenital Hypothyroidism: Target Attainment Rates Should Be Improved
por: Leroux, Stéphanie, et al.
Publicado: (2020)

MON-081 Mathematical Modeling of Residual Endogenous FT4 Synthesis and Exogenous L-Thyroxine Administration over the First 2 Years of Life in Infants with Congenital Hypothyroidism
por: Leroux, Stéphanie, et al.
Publicado: (2020)

Predictive factors of malignancy in pediatric patients with thyroid nodules and performance of the Italian classification (SIAPEC 2014) in the outcome of the cytological FNA categories
por: Tuli, Gerdi, et al.
Publicado: (2021)

Adrenal insufficiency management in the pediatric emergency setting and risk factors for adrenal crisis development
por: Abrigo, Enrica, et al.
Publicado: (2023)

Validity of Six Month L-Thyroxine Dose for Differentiation of Transient or Permanent Congenital Hypothyroidism
por: Asena, Muhammet, et al.
Publicado: (2020)

Menorrhagia as main presentation sign of severe hypothyroidism in a pediatric patient: a case report
por: Barbero, Arianna, et al.
Publicado: (2022)

Free triiodothyronine/free thyroxine ratio in children with congenital hypothyroidism
por: Sydlik, Carmen, et al.
Publicado: (2022)

Weight and Body Mass Index for Predicting Thyroxine Dose in Primary Hypothyroidism
por: Raashid, Kashif, et al.
Publicado: (2021)

Perinatal asphyxia and hypothermic treatment from the endocrine perspective
por: Improda, Nicola, et al.
Publicado: (2023)

Basal Serum Thyroxine Level should Guide Initial Thyroxine Replacement Dose in Neonates with Congenital Hypothyroidism
por: Günbey, Ceren, et al.
Publicado: (2021)

Free Thyroxine Distinguishes Subclinical Hypothyroidism From Other Aging-Related Changes in Those With Isolated Elevated Thyrotropin
por: Abbey, Enoch J., et al.
Publicado: (2022)

Severe Hypothyroidism due to the Loss of Therapeutic Efficacy of l-Thyroxine in a Patient with Esophageal Complication Associated with Systemic Sclerosis
por: Lobasso, Antonio, et al.
Publicado: (2017)

Effect on Reaction Time in Primary Hypothyroid Patients Before and After Thyroxin Treatment
por: Kale, Jyoti S, et al.
Publicado: (2022)

The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine
por: Antonelli, Alessandro, et al.
Publicado: (2021)

Efficacy and Safety of Once-Weekly Thyroxine for Thyroxine-Resistant Hypothyroidism
por: Jayakumari, Chellama, et al.
Publicado: (2019)

Diagnosis and Management of Central Congenital Hypothyroidism
por: Lauffer, Peter, et al.
Publicado: (2021)

Thyroxine Replacement for Subfertile Females With Subclinical Hypothyroidism and Autoimmune Thyroiditis: A Systematic Review
por: Myneni, Revathi, et al.
Publicado: (2021)

Effect of Prolonged Discontinuation of L-Thyroxine Replacement in a Child with Congenital Hypothyroidism
por: Kubicky, Rita Ann, et al.
Publicado: (2012)

Liquid and softgel capsules of l-thyroxine results lower serum thyrotropin levels more than tablet formulations in hypothyroid patients
por: Benvenga, Salvatore
Publicado: (2019)

PSAT366 Liquid L-thyroxine (L-T4) Formulation Normalizes TSH in Hypothyroid Patients Treated with Tablets L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

“Thyroid nodular disease and PTEN mutation in a multicentre series of children with PTEN hamartoma tumor syndrome (PHTS)”
por: Tuli, Gerdi, et al.
Publicado: (2021)

Evaluation of the Optimal Thyroxine Levels for Thyroxine Hormone Replacement in Patients With Central Hypothyroidism
por: Lee, Ka Fai, et al.
Publicado: (2021)

Daily Versus Alternate Day Thyroxine Therapy to Maintain Euthyroidism in Children With Congenital Hypothyroidism
por: Dayal, Devi, et al.
Publicado: (2013)

Unusual Course of Congenital Hypothyroidism and Route of the L-Thyroxine Treatment in a Preterm Newborn
por: Korkmaz, Levent, et al.
Publicado: (2014)

Genetics of Gland-in-situ or Hypoplastic Congenital Hypothyroidism in Macedonia
por: Zdraveska, Nikolina, et al.
Publicado: (2020)

Neonatal outcomes and congenital anomalies in pregnancies affected by hypothyroidism
por: Kiran, Zareen, et al.
Publicado: (2021)

Pharmacokinetics and Clinical Implications of Two Non-Tablet Oral Formulations of L-Thyroxine in Patients with Hypothyroidism
por: Trimboli, Pierpaolo, et al.
Publicado: (2022)

Thyroxine and treatment of hypothyroidism: seven decades of experience
por: Mateo, Roselyn Cristelle I., et al.
Publicado: (2019)

Hippocampal Functioning and Verbal Associative Memory in Adolescents with Congenital Hypothyroidism
por: Wheeler, Sarah M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6ul3tkqr5o4nr0spch6avoqctf